作者
Rosa Filiberti, Paola Marroni, Fabio Spigno, Domenico F Merlo, Virginia Mortara, Pietro Caruso, Alex Cioè, Luigi Michelazzi, Andrea Bruzzone, Barbara Bobbio, Claudio Simonassi, Lisette Del Corso, Roberto Galli, Omar Racchi, Guglielmo Dini, Roberta Linares, Manlio Mencoboni
发表日期
2014/12/21
期刊
Oncology
卷号
86
期号
1
页码范围
33-43
出版商
S. Karger AG
简介
Objective: Soluble mesothelin-related peptide (SMRP) may be useful in the diagnosis and detection of early stage mesothelioma. We investigated the SMRP upfront predictive role for mesothelioma in asbestos-exposed workers. Methods: A total of 1,715 subjects underwent a first visit and were invited for a follow-up after 1 and 2 years, with a clinical examination and blood sampling. SMRP was measured by an ELISA assay. Results: Median SMRP at the first visit was 0.45 [interquartile range (IQR) i.e. 25th-75th percentile: 0.30-0.67 nmol/l]. In all, 1,676 subjects (97.8%) were followed up for a median period of 47.1 months. SMRP was measured at the first visit and at both follow-up visits in 1,536 subjects. At follow-up, 3 subjects were diagnosed with an epithelioid mesothelioma. In these cases, SMRP at the first visit ranged from 0.17 to 0.52 nmol/l. Malignant pleural mesothelioma was …
引用总数
2014201520162017201820192020202120222023113413232